Numinus Wellness Inc News

Numinus Says FDA Decision on New Therapy "A Blow", But Adds It Is Not Dependent On New Therapies; Also Terminated LoI With MedBright AI

MT NewswiresAug 12 20:38

Numinus Wellness Comments on FDA Decision on New Drug Application for MDMA-Assisted Therapy for PTSD

PR NewswireAug 12 19:00

MedBright AI Appoints Christopher Heath as CEO, Terminates Letter of Intent With NUminus

MT NewswiresAug 9 23:53

Psychedelics Co. Numinus Narrows Loss In Q3, Reports QoQ Decrease In Revenue, Gross Profit

BenzingaJul 13 02:39

When Will Numinus Wellness Inc. (TSE:NUMI) Turn A Profit?

Yahoo FinanceJul 13 00:52

Earnings Call Summary | NUMINUS WELLNESS INC(NUMIF.US) Q3 2024 Earnings Conference

Futu NewsJul 12 10:03 · Conference Call

Numinus Wellness Fiscal Q3 Loss Down Vs Fiscal Q2 Loss, Even As Revenue Fell

MT NewswiresJul 12 05:01

Numinus Wellness Brief: Q3 Revenue of $4.3 Million, a 1.9% Decline Over Q2 2024

MT NewswiresJul 12 04:30

Press Release: Numinus Wellness Inc. Announces Third Quarter Fiscal 2024 Results

Dow JonesJul 12 04:30

Numinus to Host Q3 Fiscal 2024 Results Conference Call on July 11, 2024

PR NewswireJul 11 06:35

Press Release: Numinus Wellness Announces Resignation of Director

Dow JonesJun 25 05:30

Psychedelics-Focused Numinus Plans To Leverage This AI Technology Via New Strategic Acquisition

BenzingaJun 23 02:35

Numinus Wellness Signs Letter of Intent to Buy MedBright AI Investments

MT NewswiresJun 20 20:16

Press Release: MedBright AI Announces Strategic Acquisition by Numinus Wellness

Dow JonesJun 20 19:00

Numinus Clarifies Disclosures

newsfileJun 8 09:09

Numinus Wellness Comments on FDA Advisory Committee Meeting for Investigational MDMA-Assisted Therapy for PTSD

PR NewswireJun 7 19:27

Press Release: Numinus Wellness Announces Voting Results From Its Annual General Meeting of Shareholders

Dow JonesJun 1 07:38

Numinus Wellness Charts Path To Profitability While Strengthening Community Ties

newsfileMay 30 21:09

Numinus and Cybin Embark on a Groundbreaking Journey: Pioneering Phase 3 Trials for Major Depressive Disorder

newsfileMay 30 21:08

Numinus Wellness Brief: Says Received Health Canada Approval for Study Into Group Model for MDMA-Assisted Therapy

MT NewswiresMay 30 19:06